Bezafibrate

insulin ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33525941 Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release. 2021 Dec 1
2 25360162 Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study. 2014 1
3 23254592 Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia. 2013 Jul 1
4 23150952 Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? 2012 Nov 14 1
5 19131462 Antidiabetic action of bezafibrate in a large observational database. 2009 Apr 1
6 16606809 Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. 2006 Apr 10 1
7 12733699 Bezafibrate improves hypertension and insulin sensitivity in humans. 2003 Apr 2
8 12754275 Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy. 2003 Aug 1
9 11893366 Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. 2002 Mar 1
10 12472919 Bezafibrate-induced improvement in glucose uptake and endothelial function in protease inhibitor-associated insulin resistance. 2002 Dec 2
11 11288046 Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. 2001 Apr 2
12 10868845 Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients. 2000 Feb 1
13 10403804 Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats. 1999 Jul 5 1
14 9381994 Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients. 1997 Oct 1 1
15 7851275 Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance. 1994 Oct 2
16 1458771 Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia. 1992 Dec 1
17 2653325 Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes. 1989 Feb 1